Michael Endrodi (Dohnanyi) Salacz MD
Neuro-Oncology
Director, Neuro-Oncology Program Associate Professor of Medicine Rutgers, Cancer Institute of New Jersey Robert Wood Johnson Medical School
Join to view full profile
1 Capital WayPennington, NJ 08534
Phone+1 609-537-6363
Dr. Salacz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Salacz is a neuro-oncologist in Hopewell, NJ and Camden, NJ and is affiliated with Capital Health, Hopewell as well as Cooper Health, Camden. He received his medical degree from Rutgers - New Jersey Medical School and has been in practice 19 years. He specializes in neuro-oncology and is experienced in oligodendroglioma, ependymoma, primary central nervous system lymphoma, neuroblastoma, and glioblastoma multiforme. He has more than 20 publications and over 500 citations.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1999 - 2002- University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1998 - 1999
Rutgers New Jersey Medical SchoolClass of 1998
Certifications & Licensure
NY State Medical License 2026 - 2028
NJ State Medical License 2020 - 2027
KS State Medical License 2005 - 2021
MO State Medical License 2005 - 2021
NC State Medical License 2007 - 2008
WI State Medical License 2002 - 2005
OH State Medical License 2000 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2015-2017
- CMS Meaningful Use Stage 1 Certification RelayClinical™ Communicator, RelayHealth, a division of McKesson Corporation, 2012, 2015-2017
Clinical Trials
Publications & Presentations
PubMed
- Synchronous diagnosis of multicentric glioma with distinct isocitrate dehydrogenase molecular profiles: a case report.Aditya A Mohan, Kristen Batich, Shih-Hsiu J Wang, Giselle Y López, Michael E Salacz
CNS Oncology. 2026-12-01 - Magnetic Resonance Guided Radiation Therapy for High-Grade Glioma in Pregnancy: Planning, Validation, and Adaptive Fetal Dose Monitoring.Nikhil Mathews, Andrew Jaffe, Kevin McMichael, Navid Redjal, Elyce H Cardonick
Advances in Radiation Oncology. 2026-10-01 - 6 citationsVirtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.James L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, Lisa Boris, Yeonju Kim
Journal of Neuro-Oncology. 2024-04-01
Journal Articles
- Profiles of Brain Metastases: Prioritization of Therapeutic TargetsRaymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
Press Mentions
8 Oncologists on the MoveApril 2nd, 2021- Rutgers Cancer Institute of New Jersey Names Director of Neuro-OncologyMarch 24th, 2021
John McCain Has Died. For Brain Cancers like His, 'Research Is Our Only Hope'August 25th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
